These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 17890449)
1. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Wies E; Mori Y; Hahn A; Kremmer E; Stürzl M; Fleckenstein B; Neipel F Blood; 2008 Jan; 111(1):320-7. PubMed ID: 17890449 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus. Zhang YJ; Patel D; Nan Y; Fan S Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma. Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E mBio; 2020 Aug; 11(4):. PubMed ID: 32843547 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324 [TBL] [Abstract][Full Text] [Related]
6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications. Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ mBio; 2018 May; 9(3):. PubMed ID: 29739902 [TBL] [Abstract][Full Text] [Related]
7. p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3. Baresova P; Musilova J; Pitha PM; Lubyova B Mol Cell Biol; 2014 Feb; 34(3):386-99. PubMed ID: 24248600 [TBL] [Abstract][Full Text] [Related]
8. Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase. Xiang Q; Ju H; Li Q; Mei SC; Chen D; Choi YB; Nicholas J J Virol; 2018 Apr; 92(7):. PubMed ID: 29343584 [TBL] [Abstract][Full Text] [Related]
9. How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis. Faure A; Hayes M; Sugden B Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16519-16528. PubMed ID: 31363046 [TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression. Koch S; Damas M; Freise A; Hage E; Dhingra A; Rückert J; Gallo A; Kremmer E; Tegge W; Brönstrup M; Brune W; Schulz TF PLoS Pathog; 2019 May; 15(5):e1007743. PubMed ID: 31059555 [TBL] [Abstract][Full Text] [Related]
17. Cancers associated with human gammaherpesviruses. Wen KW; Wang L; Menke JR; Damania B FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980 [TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of a xenograft mice model for KSHV+ primary effusion lymphoma (PEL). Dai L; Trillo-Tinoco J; Bai L; Kang B; Xu Z; Wen X; Del Valle L; Qin Z PLoS One; 2014; 9(2):e90349. PubMed ID: 24587336 [TBL] [Abstract][Full Text] [Related]
19. Modulation of interferon regulatory factor 5 activities by the Kaposi sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3 contributes to immune evasion and lytic induction. Bi X; Yang L; Mancl ME; Barnes BJ J Interferon Cytokine Res; 2011 Apr; 31(4):373-82. PubMed ID: 21133648 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease. Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]